 suppress cytomegaloviru retin person aid high-dos intraven acyclovir efficaci safeti high-dos intraven acyclovir oral zidovudin suppress therapi cytomegaloviru retin patient aid single-arm outpati open-label phase II pilot studi between juli juli men aid cytomegaloviru retin salvag vision intraven acyclovir mg/kg bodi weight oral zidovudin success induct therapi intraven ganciclovir mg/kg day patient evalu weekli patient time retin progress studi concomit life-threaten infect median durat acyclovir zidovudin therapi retin progress day none uninvolv eye evaluat patient cytomegaloviru retin studi particip data high-dos intraven acyclovir zidovudin benefit cytomegaloviru retin